Paradigm Biopharmaceuticals Limited (PBIGF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -65.94 Million | -45.18 Million | -32.2 Million | -34.92 Million | -10.09 Million | -6.36 Million |
| Net Income | -58.65 Million | -51.91 Million | -39.24 Million | -34.29 Million | -12.29 Million | -15.62 Million |
| Depreciation & Amortization | 146.73 Thousand | 153.65 Thousand | 193.25 Thousand | 210.05 Thousand | 213.11 Thousand | 8348.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.2 Million | 936.46 Thousand | 3.27 Million | 3.2 Million | 1.27 Million | 2.04 Million |
| Change in working capital | -8.68 Million | 5.33 Million | 4.43 Million | -3.73 Million | 718.2 Thousand | 282.94 Thousand |
| Other non-cash items | 9.15 Million | 1.23 Million | 2.41 Million | 2.89 Million | 1.27 Million | 8.97 Million |
| Investing Cash Flow | - | - | - | 668.36 Thousand | 5.62 Million | -6.52 Million |
| Investments in PPE | - | - | - | -31.63 Thousand | -130.89 Thousand | -21.97 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -6.5 Million |
| Sales/Maturities of investments | - | - | - | 700 Thousand | 5.75 Million | - |
| Other Investing Activities | - | - | - | 699.15 Thousand | 5.75 Million | -6.5 Million |
| Financing Cash Flow | 28.17 Million | 62.53 Million | 70.11 Thousand | 1 Million | 36.05 Million | 82.77 Million |
| Debt repayment | -102.33 Thousand | -416.34 Thousand | -205.28 Thousand | -121.84 Thousand | -93.56 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.83 Million | -3.76 Million | - | - | -2.58 Million | -5.26 Million |
| Common Stock Issuance | 28.27 Million | 65.98 Million | - | 1.02 Million | 36.83 Million | 88.04 Million |
| Other Financing Activities | -102.33 Thousand | 1.14 Million | 275.4 Thousand | -18.17 Thousand | 1.8 Million | 82.77 Million |
| Accounts receivables | 1.72 Million | -88.5 Thousand | 1.78 Million | -4.99 Million | 22.45 Thousand | -797.44 Thousand |
| Accounts payables | -9.34 Million | 5.07 Million | 2.1 Million | 2.2 Million | 751.02 Thousand | 1.12 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.06 Million | 349.35 Thousand | 548.73 Thousand | -939.65 Thousand | -55.26 Thousand | -45.14 Thousand |
| Cash at beginning of period | 56.33 Million | 39.67 Million | 71.03 Million | 103.92 Million | 72.33 Million | 2.44 Million |
| Cash at end of period | 17.82 Million | 56.33 Million | 39.67 Million | 71.03 Million | 103.92 Million | 72.33 Million |
| Capital Expenditure | - | - | - | -31.63 Thousand | -130.89 Thousand | -21.97 Thousand |
| Effect of forex changes on cash | -744.54 Thousand | -689.67 Thousand | 774.58 Thousand | 371.29 Thousand | - | - |
| Net cash flow / Change in cash | -38.51 Million | 16.65 Million | -31.36 Million | -32.88 Million | 31.58 Million | 69.89 Million |
| Free Cash Flow | -65.94 Million | -45.18 Million | -32.2 Million | -34.96 Million | -10.22 Million | -6.38 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.84 Million | -58.65 Million | -4.84 Million | -48.95 Million | -24.47 Million | -51.91 Million |
| Depreciation & Amortization | 36.66 Thousand | 146.73 Thousand | 36.66 Thousand | 73.39 Thousand | 36.69 Thousand | 153.65 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 185.02 Thousand | - | 185.02 Thousand | 415.07 Thousand | 415.07 Thousand | 936.46 Thousand |
| Change in working capital | 726.05 Thousand | -8.68 Million | 726.05 Thousand | -3.04 Million | -398.53 Thousand | 5.33 Million |
| Other non-cash items | -3.56 Million | 9.15 Million | -3.56 Million | 3.92 Million | -1.08 Million | 1.23 Million |
| Investing Cash Flow | -23.1 Thousand | - | -23.1 Thousand | 46.2 Thousand | 23.1 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | -46.2 Thousand | - | - | 46.2 Thousand | - | - |
| Other Investing Activities | -23.1 Thousand | - | -23.1 Thousand | 23.1 Thousand | 23.1 Thousand | - |
| Financing Cash Flow | -62.77 Thousand | 28.17 Million | -62.77 Thousand | 28.3 Million | 14.15 Million | 62.53 Million |
| Debt repayment | - | - | - | - | - | -416.34 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -3.76 Million |
| Common Stock Issuance | -74.56 Thousand | 28.27 Million | - | 28.35 Million | - | 65.98 Million |
| Other Financing Activities | -62.77 Thousand | - | -62.77 Thousand | 14.15 Million | 14.15 Million | 1.14 Million |
| Accounts receivables | 1.16 Million | 1.72 Million | 1.16 Million | -619.55 Thousand | -521.27 Thousand | -88.5 Thousand |
| Accounts payables | -7.09 Million | -9.34 Million | - | -2.24 Million | - | 5.07 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -438.18 Thousand | -1.06 Million | -438.18 Thousand | -177.51 Thousand | 122.74 Thousand | 349.35 Thousand |
| Cash at beginning of period | 33.55 Million | 56.33 Million | - | 56.33 Million | - | 39.67 Million |
| Cash at end of period | 17.82 Million | 17.82 Million | -7.86 Million | 33.55 Million | -11.39 Million | 56.33 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -318.31 Thousand | - | -318.31 Thousand | -53.95 Thousand | -53.95 Thousand | -689.67 Thousand |
| Net cash flow / Change in cash | -15.73 Million | -38.51 Million | -7.86 Million | -22.78 Million | -11.39 Million | 16.65 Million |
| Free Cash Flow | -7.46 Million | -65.94 Million | -7.46 Million | -51.02 Million | -25.51 Million | -45.18 Million |
603612
000560
3083
6605
1423
BINANIIND